Precision Biosciences (DTIL) Free Cash Flow Growth (1y) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 60.84% |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 88.70% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -15.72% |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 66.37% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 3.98% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 137.65% |
| 10 | Precision Biosciences | 171.70 Mn | 70.52 Mn | - | 37.46% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 37.46% |
| Dec 31, 2025 | 39.99% |
| Sep 30, 2025 | -156.60% |
| Jun 30, 2025 | -36.09% |
| Mar 31, 2025 | -0.26% |
| Dec 31, 2024 | -123.65% |
| Sep 30, 2024 | 74.65% |
| Jun 30, 2024 | 32.93% |
| Mar 31, 2024 | 40.39% |
| Dec 31, 2023 | 62.64% |
| Sep 30, 2023 | -183.57% |
| Jun 30, 2023 | 11.17% |
| Mar 31, 2023 | -7.73% |
| Dec 31, 2022 | 10.76% |
| Sep 30, 2022 | 214.04% |
| Jun 30, 2022 | 24.30% |
| Mar 31, 2022 | -144.35% |
| Dec 31, 2021 | -73.12% |
| Sep 30, 2021 | -5.88% |
| Jun 30, 2021 | -19.73% |
| Mar 31, 2021 | 347.83% |
| Dec 31, 2020 | 44.23% |
| Sep 30, 2020 | -16.96% |
| Jun 30, 2020 | -11.63% |
| Mar 31, 2020 | -8.10% |
| Dec 31, 2019 | -14.49% |
| Sep 30, 2019 | -12.36% |
| Jun 30, 2019 | -136.75% |
| Mar 31, 2019 | -65.79% |